Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Phone305-412-4430
Employees
Founded2001

Offices

Miami, USA
8305 NW 27th Street
27th Street
Miami, FL, 33122
USA

People

Chief Financial Officer and Secretary
President & CEO
Chief Scientific Officer

Funding

TOTAL $12.8M
FUNDING TOTAL $12.8M
Partial Close, 10/2012
$1.37M
Private Equity, 8/2013
River Cities Capital Funds
Ballast Point Ventures
$10M
Partial Close, 10/2013
$1.42M

Tags

Tissuetech

Founded in 2001 by Amy Tseng, President and CEO, and Dr. Scheffer Tseng, Chairman and Chief Scientific Officer, TissueTech, Inc. is a leader in regenerative amniotic tissue-based products for use in the ophthalmology, optometry, musculoskeletal and wound care markets. The National Institutes of Health (NIH) has supported TissueTech’s research with more than 25 continuous years of research grants. Since inception, 150,000 human implants have been conducted using the Company’s patented CryoTek™ process and 300 peer-reviewed scientific publications have been produced supporting the technology

platform. The Company has pioneered the clinical application of human amniotic membrane and its role in stem cell research. The Company’s first product, AmnioGraft™, is the only tissue graft designated by the FDA as homologous for promoting ophthalmic wound healing while suppressing scarring and inflammation.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. TissueTech Completes $10M Growth Equity Financing (finsmes.com) [edit]
  3. SEC (sec.gov) [edit]
Edit This Page
Last Edited 2/9/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy